Czechia vs Slovakia: Cause of death, by non-communicable diseases, ages 5-14
Czechia
57.8%
in 2021
Slovakia
58.1%
in 2021
Czechia rank
38th
Slovakia rank
36th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Czechia
- Slovakia
How they compare
Slovakia currently reports 58.1% against 57.8% in Czechia, a difference of 0.3%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Slovakia ahead.
Czechia ranks 38th and Slovakia ranks 36th of 185 countries.
Across the 3 decades both report, Czechia averaged higher in 1 and Slovakia in 2.
Head to head by decade
| Decade | Czechia | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.8% | 49.9% | 5.1% | Slovakia |
| 2010s | 55.6% | 58.3% | 2.7% | Slovakia |
| 2020s | 56.8% | 56.1% | 0.7% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Czechia or Slovakia?
- Slovakia, at 58.1% against 57.8% in Czechia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Czechia and Slovakia?
- 0.3%, with Slovakia ahead.
- How many years of comparable data are there for Czechia and Slovakia?
- 6 years are reported by both, from 2000 to 2021.
- How do Czechia and Slovakia rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Czechia ranks 38th and Slovakia ranks 36th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.